Studies involving high-fat diet      

Filter by:
Data set Procedure What's in this data set Panel Sex Age (weeks) Year
Albers1 lipid profile
with high-fat diet
Cholesterol, HDL, non-HDL, triglycerides, phospholipids. 4h fast, plasma. Baseline vs. high-fat diet (6wks). inbred   (15) both 6-14wks 1999
Albers1 protein activity assessment
with high-fat diet
Phospholipid transfer protein activity. 4h fast. inbred   (15) both 6-14wks 1999
Auwerx1 body temperature
with high-fat diet
In cold room: 0, 1, 2, 3, 4, 5, 6 h. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 body weight
with high-fat diet
8-29 wks of age. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 cell signaling molecule detection
with high-fat diet
INF-gamma, interleukins, monocyte chemoattractant, macrophage inflammatory protein, T cell RANTES, TNF-alpha. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 complete blood count
with high-fat diet
RBC, hematocrit. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 glucose tolerance
with high-fat diet
Glucose post oral gavage: 0, 15, 30, 45, 60, 90, 120, 150, 180 min plus area under curve. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 hormone quantification
with high-fat diet
Glucose post oral gavage: 0, 15, 30 min plus area under curve. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 intake monitoring
with high-fat diet
Food intake. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 lipid profile
with high-fat diet
Cholesterol, HDL, LDL, free fatty acids, triglyceride. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 metabolic panel
with high-fat diet
Enzymes, bile acid, proteins, creatinine, glucose, iron, lactate. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 monitoring system
with high-fat diet
Oxygen consumption and respiratory exchange ratio (RER); activity. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 NMR
with high-fat diet
Body composition. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 organ weights
with high-fat diet
Skeletal muscle, soleus muscle, heart, kidney, liver, various fat pads. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 running wheel monitoring
with high-fat diet
Distance traveled, speed. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 tail cuff
with high-fat diet
Blood pressure and heart rate. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 treadmill endurance test
with high-fat diet
Distance traveled. BXD w/par   (57) m 8-29 wks 2016
Auwerx2 body weight
with high-fat diet
inbred w/CC8 both 8-21 wks 2021
Auwerx2 glucose tolerance
with high-fat diet
Plasma glucose levels: 0, 15, 30, 45, 60, 90, 120, 150, and 180 min, post oral gavage following overnight fast. inbred w/CC8 both 8-21 wks 2021
Auwerx2 hormone quantification
with high-fat diet
Insulin levels following glucose post oral gavage: 0, 15, 30 min. inbred w/CC8 both 8-21 wks 2021
Auwerx2 intake monitoring
with high-fat diet
Food intake. inbred w/CC8 both 8-21 wks 2021
Auwerx2 lipid profile
with high-fat diet
Cholesterol, HDL, LDL, triglycerides, free fatty acids. inbred w/CC8 both 8-21 wks 2021
Auwerx2 metabolic panel
with high-fat diet
Enzymes, creatinine, iron, lactate, urea. inbred w/CC8 both 8-21 wks 2021
Auwerx2 monitoring system
with high-fat diet
Oxygen consumption, carbon dioxide production, respiratory exchange rate (RER); activity. inbred w/CC8 both 8-21 wks 2021
Auwerx2 organ dimensions
with high-fat diet
Intestine length. inbred w/CC8 both 8-21 wks 2021
Auwerx2 organ weights
with high-fat diet
Cecum, muscles, heart, heart-atria, kidney, liver, spleen, fat pads. inbred w/CC8 both 8-21 wks 2021
Auwerx2 treadmill endurance test
with high-fat diet
Distance traveled. inbred w/CC8 both 8-21 wks 2021
Cheverud1 body weight
with high-fat diet
Body weight and growth curve from age 1wk to 22wks (pre-wean, post-wean, adult). High-fat diet (17wks) vs. control. LGXSM w/par   (19) both 12-16wks 2004
Cheverud1 fat pad weights
with high-fat diet
High-fat diet (17wks) vs. control. LGXSM w/par   (19) both 12-16wks 2004
Cheverud1 glucose tolerance
with high-fat diet
High-fat diet (17wks) vs. control. 0 to 120 min after 10% glucose i.p. 4h fast. LGXSM w/par   (19) both 12-16wks 2004
Cheverud1 hormone quantification
with high-fat diet
Insulin, leptin. LGXSM w/par   (19) both 12-16wks 2004
Cheverud1 lipid profile
with high-fat diet
Cholesterol, triglycerides, free fatty acids. High-fat diet (17wks) vs. control. 4h fast, serum. LGXSM w/par   (19) both 12-16wks 2004
Cheverud1 organ weights
with high-fat diet
Heart, liver, kidney, spleen weights after high-fat diet (17wks) vs. control. LGXSM w/par   (19) both 12-16wks 2004
HMDPpheno11 histopathology
with high-fat high-cholesterol diet
Aortic lesion size after 16 wks on high-fat diet. HMDP hAPOE and hCETP transgenic   (103) both 23-25 wks 2015
Ishimori1 study archive
with high-fat diet
Lipids, atherosclerosis lesions, parathyroid hormone after high-fat diet. QTL population f 20wks 2004
Jaxpheno11 study archive
with high-fat diet
High-fat diet and early stages of type 2 diabetes. one strain: C57BL/6J m 2017
Jaxpheno15 study archive
with high-fat diet
Effects of a 10% fat diet. one strain: B6.Cg-Lep/J both 4-16wks 2018
Lyons1 study archive
with high-fat diet
Lipids (plasma), liver weight, gallbladder and gallstone histopathology. QTL population m 16-18wks 2003
Lyons2 study archive
with high-fat diet
Lipids (plasma), bile, liver weight, gallbladder and gallstone histopathology. QTL population m 16-18wks 2003
Lyons3 study archive
with high-fat diet
Lipids, gallbladder and gallstone histopathology after high-fat diet. QTL population m 14-20wks 2004
Morgan1 body weight
with high-fat diet and olanzapine
Body weight and growth curve from age 8wks to 18wks weighed every 2wks. Olanzapine vs. control (both groups high-fat diet). inbred w/CC8   (9) f 8-18wks 2014
Nadeau1 body weight
with high-fat diet
Baseline vs. high-fat diet for 12wks. B6.A consomic w/par   (24) m 5, 17 wks 2008
Naggert1 body weight
with high-fat diet
High-fat diet for 8wks. inbred w/CC7   (43) both 5, 21 wks 2003
Naggert1 DXA
with high-fat diet
Body mass, fat mass, lean mass, bone mineral density and content after 8wks on high-fat diet. inbred w/CC7   (43) both 5, 21 wks 2003
Naggert1 hormone quantification
with high-fat diet
Insulin and leptin after 18wks on high-fat diet. Multiple readings per animal were averaged. inbred w/CC7   (43) both 5, 21 wks 2003
Naggert1 metabolic panel
with high-fat diet
Glucose (plasma). Baseline vs. high-fat diet (17wks). 4h fast. inbred w/CC7   (43) both 5, 21 wks 2003
Paigen1 body weight
with high-fat diet
Baseline vs. high-fat diet for 8wks. inbred   (44) both 15-19wks 2000
Paigen1 histopathology
with high-fat diet
Gallstone, gallbladder, and atherosclerosis lesion histopathology after 8wks on high-fat diet. inbred   (44) both 15-19wks 2000
Paigen1 lipid profile
with high-fat diet
Cholesterol, HDL, non-HDL. 4h fast, plasma. Hepatic lipids. 8wks on high-fat diet. inbred   (44) both 15-19wks 2000
Paigen1 metabolic panel
with high-fat diet
Alanine transaminase, bile salts (plasma) after 8wks on high-fat diet. 4h fast. inbred   (44) both 15-19wks 2000
Paigen1 organ dimensions
with high-fat diet
Gallbladder volume after 8wks on high-fat diet. inbred   (44) both 15-19wks 2000
Paigen1 organ weights
with high-fat diet
Liver weight after 8wks on high-fat diet. inbred   (44) both 15-19wks 2000
Paigen2 histopathology
with high-fat diet
Aortic lesion size histopathology. Baseline vs. high-fat diet (17wks). inbred w/CC7   (43) both 7-9wks, 24-27wks 2002
Paigen2 lipid profile
with high-fat diet
Cholesterol, HDL, non-HDL, triglycerides. Baseline vs. high-fat diet (17wks). 4h fast, plasma. inbred w/CC7   (43) both 7-9wks, 24-27wks 2002
Paigen3 body weight
with high-fat diet
Baseline vs. high-fat diet for 8wks. obesity mutants   (8) both 15-19wks 2000
Paigen3 histopathology
with high-fat diet
Gallstone, gallbladder, and atherosclerosis lesion histopathology after 8wks on high-fat diet obesity mutants   (8) both 15-19wks 2000
Paigen3 lipid profile
with high-fat diet
Cholesterol, HDL, non-HDL. 4h fast, plasma. Hepatic lipids. 8wks on high-fat diet. obesity mutants   (8) both 15-19wks 2000
Paigen3 metabolic panel
with high-fat diet
Alanine transaminase, bile salts (plasma) after 8wks on high-fat diet. 4h fast. obesity mutants   (8) both 15-19wks 2000
Paigen3 organ dimensions
with high-fat diet
Gallbladder volume after 8wks on high-fat diet obesity mutants   (8) both 15-19wks 2000
Paigen3 organ weights
with high-fat diet
Liver weight after 8wks on high-fat diet. obesity mutants   (8) both 15-19wks 2000
Pitman1 study archive
with high-fat diet
Cholesterol (plasma) after high-fat diet (several timepoints). QTL population f 6-26wks 2002
Reed2 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. High-fat diet vs. control. Two age cohorts. B6.129 and 129.B6 consomic w/par   (9) both 26wks 2015
Rusyn5 alcohol quantification
with high-fat diet and ethanol
Alcohol concentration in blood and urine after 4 wk regimen of ethanol vs. control, both groups on high-fat diet. 24h fast. inbred   (14) m 8-14wks 2011
Rusyn5 histopathology
with high-fat diet and ethanol
Liver histopathology, injury after 4wk regimen of ethanol vs. control, both groups on high-fat diet. 24h fast. inbred   (14) m 8-14wks 2011
Rusyn5 lipid profile
with high-fat diet and ethanol
Hepatic triglycerides after 4wk regimen of ethanol and high-fat diet. 24h fast. inbred   (14) m 8-14wks 2011
Rusyn5 metabolic panel
with high-fat diet and ethanol
Alanine transaminase (serum) after 4wk regimen of ethanol vs. control, both groups on high-fat diet. 24h fast. inbred   (14) m 8-14wks 2011
Rusyn5 metabolite quantification
with high-fat diet and ethanol
Homocysteine concentration after 4wk regimen of ethanol vs. control, both groups on high-fat diet. 24h fast. inbred   (14) m 8-14wks 2011
Rusyn5 organ weights
with high-fat diet and ethanol
Liver weight after 4wk regimen of ethanol vs. control, both groups on high-fat diet. 24h fast. inbred   (14) m 8-14wks 2011
Rusyn5 RNA expression profiling
with high-fat diet and ethanol
Liver gene expression after 4wk regimen of ethanol and high-fat diet. 24h fast. mRNA abundance relative to the control (high-fat only) group. inbred   (14) m 8-14wks 2011
Schoonjans1 biomarker quantification
with high-fat diet
Bile acid levels in plasma, feces, and liver. BXD w/par   (36) m 8-29 wks 2022
Schoonjans1 body weight
with high-fat diet
At 8, 20 and 29 wks of age. BXD w/par   (36) m 8-29 wks 2022
Schoonjans1 glucose tolerance
with high-fat diet
Plasma glucose levels at 0, 30, 60 min post oral gavage of Ensure Plus, overday fast. BXD w/par   (36) m 8-29 wks 2022
Schoonjans1 organ dimensions
with high-fat diet
Small intestine length. BXD w/par   (36) m 8-29 wks 2022
Schoonjans1 organ weights
with high-fat diet
Liver, spleen, kidney, fat pads, muscles, cecum. BXD w/par   (36) m 8-29 wks 2022
Shockley1 body weight
with high-fat diet
High-fat diet for 4wks vs. control. inbred   (10) both 10-13wks 2008
Shockley1 lipid profile
with high-fat diet
Cholesterol, HDL, triglycerides, fatty acids. High-fat diet (4wks) vs. control. 5h fast, serum. inbred   (10) both 10-13wks 2008
Shockley1 metabolic panel
with high-fat diet
Clinical blood chemistry measures (serum). High-fat diet (4wks) vs. control. inbred   (10) both 10-13wks 2008
Stylianou1 study archive
with high-fat diet
Body size, weight, fat pad weights after high-fat diet. QTL population both 24wks 2006
Su2 study archive
with high-fat diet
Lipids (plasma). Cholesterol, triglycerides, aortic lesions, body mass index. QTL population f 14wks 2009
Wang1 study archive
with high-fat diet
Lipids (plasma). Cholesterol, inducibility, triglycerides, atherosclerosis lesions. QTL population f 10-23wks 2003
Wittenburg1 study archive
with high-fat diet
Liver weight, gallbladder and gallstone histopathology. QTL population both 18-20wks 2002
Wittenburg2 study archive
with high-fat diet
Lipids (plasma), liver weight, gallbladder and gallstone histopathology. QTL population both 6-16wks 2003
Wittenburg3 study archive
with high-fat diet
Lipids (plasma), liver weight, gallbladder and gallstone histopathology. QTL population both 2005